Determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detection

This publication has 11 references indexed in Scilit:

• Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxinN-methyl-4-phenylpyridinium (MMP+) towards cultured dopaminergic neuroblastoma cells
  Psychopharmacology, 1995
• Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6
  European Journal of Clinical Pharmacology, 1993
• High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations
  Journal of Chromatography B: Biomedical Sciences and Applications, 1993
• Freezing action of a metabolite of haloperidol in frogs
  Biochemical Pharmacology, 1992
• Haloperidol Disposition Is Dependent on Debrisoquine Hydroxylation Phenotype
  Therapeutic Drug Monitoring, 1992
• Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite
  Toxicology Letters, 1991
• Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite
  Chemical Research in Toxicology, 1991
• Metabolites of haloperidol display preferential activity at σ receptors compared to dopamine D-2 receptors
  European Journal of Pharmacology, 1990
• Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats
  Biochemical and Biophysical Research Communications, 1990
• Distribution, excretion and metabolism of neuroleptics of the butyrophenone type: Part I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat
  European Journal of Pharmacology, 1967